EUVIMEDEUVIMED entdecken
Crossref

‘Old is gold’ hydralazine, a magic bullet for dry eye disease

Biao Ma, Muhammad Ikram Anwar, Leiming Wang, Jinying Qiu, Weijun Shen

The Journal of Biochemistry · 26.10.2026

DOI: 10.1093/jb/mvag072 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Biochemistry, online erschienen am 26.10.2026. Verfasst von Biao Ma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Shaoxing Biomedical Innovation Center, Shaoxing 312025, Zhejiang, China. Die Arbeit nennt 27 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dry eye disease (DED) is a highly prevalent ocular condition characterized by insufficient tear production or poor tear quality, leading to inflammation, discomfort and potential vision impairment. Current treatments, primarily artificial tears and limited prescription options like steroids, often provide only partial or temporary relief, underscoring the critical need for more effective and safer therapeutic strategies. A key pathological driver of DED is oxidative stress, which generates reactive aldehyde species (RASP) like malondialdehyde and 4-hydroxy Hexenal. These cytotoxic electrophiles form adducts with cellular macromolecules, causing widespread damage. This work explores a therapeutic approach focused on scavenging RASP to mitigate this damage. Inspired by the known carbonyl-scavenging ability of the hydrazide group, we found hydralazine, an anti-hypertensive drug, which contains a highly nucleophilic hydrazide group, can react rapidly with aldehydes to form stable, non-toxic products. This compound is engineered to be a potent scavenger of RASP, offering a promising new avenue for the treatment of DED by directly targeting a root cause of oxidative cellular damage.

Autor:innen und Institutionen

  • Shaoxing Biomedical Innovation Center, Shaoxing 312025, Zhejiang, China.
  • Translational Innovation Center, 551667 Shenzhen Bay Laboratory, Shenzhen 518132, Guangdong, China.
  • Center for Translational Research, Changping Laboratory, Beijing 102206, China.

Zitieren

APA

Ma, B., Anwar, M. I., Wang, L., Qiu, J., & Shen, W. (2026). ‘Old is gold’ hydralazine, a magic bullet for dry eye disease. The Journal of Biochemistry. https://doi.org/10.1093/jb/mvag072

Vancouver

Ma B, Anwar MI, Wang L, Qiu J, Shen W. ‘Old is gold’ hydralazine, a magic bullet for dry eye disease. The Journal of Biochemistry. 2026. doi:10.1093/jb/mvag072

BibTeX
@article{Ma2026,
  author = {Ma, Biao and Anwar, Muhammad Ikram and Wang, Leiming and Qiu, Jinying and Shen, Weijun},
  title = {‘Old is gold’ hydralazine, a magic bullet for dry eye disease},
  journal = {The Journal of Biochemistry},
  year = {2026},
  doi = {10.1093/jb/mvag072}
}
Kostenlos starten →